<SEC-DOCUMENT>0001193125-21-204896.txt : 20210817
<SEC-HEADER>0001193125-21-204896.hdr.sgml : 20210817
<ACCEPTANCE-DATETIME>20210630172653
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-21-204896
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20210630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CS Disco, Inc.
		CENTRAL INDEX KEY:			0001625641
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				464254444
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		3700 N. CAPITAL OF TEXAS HIGHWAY
		STREET 2:		SUITE 150
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
		BUSINESS PHONE:		713-231-9100

	MAIL ADDRESS:	
		STREET 1:		3700 N. CAPITAL OF TEXAS HIGHWAY
		STREET 2:		SUITE 150
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g176601g0610083319686.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicole C. Brookshire</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1 212 479 6157</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">brookshire@cooley.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">Via EDGAR</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.50em; font-size:10pt; font-family:Times New Roman"><B>CERTAIN PORTIONS OF THIS LETTER HAVE BEEN OMITTED FROM THE VERSION FILED VIA EDGAR. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH
RESPECT TO THE OMITTED PORTIONS. INFORMATION THAT WAS OMITTED IN THE EDGAR VERSION HAS BEEN NOTED IN THIS LETTER WITH A PLACEHOLDER IDENTIFIED BY THE MARK &#147;[***]&#148;.</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2021 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S.
Securities and Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Office of Technology </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, N.E. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%" VALIGN="top" ALIGN="left">Attention:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ryan Rohn </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Stephen Krikorian </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Alexandra Barone </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Larry Spirgel </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CS Disco, Inc. </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Filed June&nbsp;25, 2021 </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>File No.&nbsp;333-257435 </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of CS Disco, Inc. (the
&#147;<B><I>Company</I></B>&#148;), we are supplementally providing the staff (the &#147;<B><I>Staff</I></B>&#148;) of the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) with information regarding the proposed price
range of the shares of the Company&#146;s common stock (the &#147;<B><I>Common Stock</I></B>&#148;) to be offered in the proposed initial public offering (the &#147;<B><I>IPO</I></B>&#148;) pursuant to the Company&#146;s Registration Statement on
Form <FONT STYLE="white-space:nowrap">S-1</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-257435),</FONT> filed with the Commission on June&nbsp;25, 2021 (the &#147;<B><I>Registration Statement</I></B>&#148;). This letter supplements the
Company&#146;s response (the &#147;<B><I>Prior Response</I></B>&#148;) to comment number 7 received from the Staff by letter dated June&nbsp;3, 2021, relating to the Company&#146;s draft Registration Statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-1,&nbsp;as</FONT> originally confidentially submitted to the Staff on May&nbsp;7, 2021, and amended on June&nbsp;14, 2021. The Prior Response set forth a breakdown of all equity awards granted by the
Company for the last six months of fiscal 2020 and in the current fiscal year through the date of the Prior Response as well as the fair value of the underlying common stock used to value such awards, as determined by the Company&#146;s board of
directors (the &#147;<B><I>Board</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we are responding to comments (the &#147;<B><I>Comments</I></B>&#148;) received from the
Staff by letter dated June&nbsp;28, 2021 with respect to the Registration Statement. The Company intends to file an amended Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> in advance of the launch of the Company&#146;s
roadshow, which will include changes that reflect the responses to the Comments as well as certain other updates to the Registration Statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 500 Boylston
Street, 14th Floor Boston, MA 02116-3736 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">t: (617) 937-2300 f: (617) 937-2400 cooley.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g176601g0630214312461.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 30, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Two </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Confidential Treatment Request </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to the commercially sensitive nature of information contained in this letter, the Company hereby requests, pursuant to 17 C.F.R. &#167;200.83, that certain
portions of this letter be maintained in confidence, not be made part of any public record and not be disclosed to any person. The Company has filed a separate copy of this letter, marked to show the portions redacted from the version filed via
EDGAR and for which the Company is requesting confidential treatment. In accordance with 17 C.F.R. &#167;200.83(d)(1), if any person (including any governmental employee who is not an employee of the Commission) should request access to or an
opportunity to inspect this letter, we request that we be immediately notified of any such request, be furnished with a copy of all written materials pertaining to such request (including, but not limited to, the request itself) and be given at
least ten business days&#146; advance notice of any intended release so that the Company may, if it deems it to be necessary or appropriate, pursue any remedies available to it. In such event, we request that you telephone the undersigned, as noted
below, rather than rely on the U.S. mail for such notice. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preliminary IPO Price Range </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company supplementally advises the Staff that it preliminarily estimates a price range of $[***] to $[***] per share (the &#147;<B><I>Preliminary Price
Range</I></B>&#148;) for the IPO. The Preliminary Price Range has been estimated based, in part, upon current market conditions, the Company&#146;s financial condition and prospects and ongoing discussions regarding market conditions between senior
management of the Company and representatives of the underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will include a bona fide price range, which the Company currently expects
to be a three-dollar range, in an amendment to the Registration Statement that would be filed shortly before the commencement of the Company&#146;s road show. We are providing this information to you supplementally to facilitate your review process.
In addition, the Company advises the Staff that it anticipates effecting a reverse split of its common stock prior to the date of the IPO. The Company notes that share and per share amounts in this letter do not give effect to the impact of such
reverse stock split. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Historical Fair Value Determination and Methodology </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Prior Response contains a discussion of the determination of the fair market value per share of the Company&#146;s common stock for financial reporting
purposes by the Board for the last six months of fiscal 2020 through June&nbsp;11, 2021, including a full description of the valuation methods used, including the income approach, the market approach and the Guideline Public Company Method, and the
other key considerations of the Board. There have been no equity grants subsequent to the date of the Prior Response Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As is typical in an IPO, the
Preliminary Price Range was not derived using a formal determination of fair value, but rather was determined based on discussions between the Company and the underwriters. In setting the Preliminary Price Range, the following factors were
considered: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the general conditions of the securities market and the recent market prices of, and the demand for, publicly
traded common stock of comparable companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s financial condition and prospects; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">estimates of business potential and earnings prospects for the Company and the industry in which it operates; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recent performance of IPOs of companies in the Company&#146;s sector. </P></TD></TR></TABLE>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 500 Boylston Street, 14th Floor Boston, MA 02116-3736 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">t: (617) 937-2300 f: (617) 937-2400 cooley.com </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g176601g0630214312461.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 30, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Three </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company believes that the difference between the $3.74 per share estimated fair
value of its common stock described in the Prior Response and the Preliminary Price Range of $[***] to $[***] per share is the result of the Company&#146;s evaluation of the factors above, as well as the following considerations: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Preliminary Price Range assumes a successful IPO in July 2021 with no weighting placed on any other outcome
of the Company, such as an acquisition or remaining private. Therefore, the Preliminary Price Range effectively weighs a near-term IPO outcome at 100%. In contrast, the March&nbsp;31, 2021 Valuation Report weighted different outcomes including
(i)&nbsp;a successful IPO by July&nbsp;31, 2021 at [***]%, (ii) a successful IPO by July&nbsp;31, 2022 at [***]% and (iii)&nbsp;private merger transaction by July&nbsp;31, 2023 at [***]%. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Preliminary Price Range represents a future price for shares of common stock that, if issued in the IPO, will
be immediately freely tradable in a public market, whereas the estimated fair values of the common stock as of March&nbsp;31, 2021 appropriately represent contemporaneous estimates of the fair value of shares that were then illiquid and might never
become liquid, and as such, were adjusted for a discount due to lack of marketability. The prior valuations applied a discount to the fair value determinations for lack of marketability, which was [***]% at March&nbsp;31, 2021.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Preliminary Price Range took into account the recent performance and valuations of public companies that the
Lead Underwriters expect will be viewed by investors as comparable to the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Preliminary Price Range took into account the recent performance of successful initial public offerings of
technology companies. Since August 2019, a number of technology companies have either completed or made public filings for their initial public offerings, suggesting a favorable market for companies that are similar to the Company in executing and
completing initial public offerings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Since June&nbsp;11, 2021, the Company has taken several steps towards the completion of an IPO, including holding
&#147;testing the waters&#148; meetings, at which the Company received feedback from potential investors, engaging additional underwriters, and publicly filing the Registration Statement with the Commission. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The successful completion of an IPO would strengthen the Company&#146;s balance sheet, provide access to public
equity and debt markets and provide a &#147;currency&#148; of publicly tradable securities to enable the Company to make strategic acquisitions as the Board may deem appropriate, providing enhanced operational flexibility. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In light of the Preliminary Price Range and the other factors described in this letter, the Company respectfully advises the Staff that it believes that the
deemed per share fair values of the Common Stock used as the basis for determining stock-based compensation expense in connection with its equity award grants have been reasonable and appropriate. </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 500 Boylston Street, 14th Floor Boston, MA 02116-3736 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">t: (617) 937-2300 f: (617) 937-2400 cooley.com </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g176601g0630214312461.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 30, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Four </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Comments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth below are the Company&#146;s responses to the Comments. The numbering of the paragraphs below corresponds to the numbering of the Comments, which for
your convenience we have incorporated into this letter in italics. Capitalized terms used but not otherwise defined in this letter have the meanings assigned to them in the Registration Statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Note 15. Subsequent Events, page <FONT STYLE="white-space:nowrap">F-27</FONT> </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><I>1.</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>We note you granted 2.7&nbsp;million options on May&nbsp;2, 2021. Please expand your disclosure to disclose
the weighted-average exercise price per share and the expected stock-based compensation to be recognized. Refer to ASC
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">855-10-50-2.</FONT></FONT></FONT> </I></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company advises the Staff that the weighted-average exercise price per share with respect to the options granted on May&nbsp;2, 2021 is
$3.74 per share. The Company estimates the aggregate amount of stock-based compensation expense that the Company will recognize for the May&nbsp;2 grants, which include options and restricted stock awards, to be approximately $8.9&nbsp;million,
based on the $3.74 per share valuation of the common stock described in the Prior Response. The Company expects to recognize this stock-based compensation cost over a weighted-average requisite service period of approximately 4.0 years. The Company
will revise the disclosure in the Registration Statement to include this information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>General </U></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><I>2.</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Please revise the graphics at the forefront of the registration statement to present a balanced picture of
the company&#146;s financial health. In this respect, we note that the company incurred a net loss of $14.5&nbsp;million as of the last twelve months ended March&nbsp;31, 2021 and indication of such should be given equal prominence with the current
presentation emphasizing revenue growth. Refer to Securities Act Forms C&amp;DI 101.02 </I></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company will revise the
graphics at the forefront of the Registration Statement in the next amendment to the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;* </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cooley LLP
500 Boylston Street, 14th Floor Boston, MA 02116-3736 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">t: (617) 937-2300 f: (617) 937-2400 cooley.com </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g176601g0630214312461.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 30, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Five </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please contact me at (212) <FONT STYLE="white-space:nowrap">479-6157</FONT> or my
colleague Jodie Bourdet at (415) <FONT STYLE="white-space:nowrap">693-2054</FONT> with any questions or further comments regarding our response to the Staff&#146;s comment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Nicole Brookshire </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nicole Brookshire </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kiwi Camara, <I>CS Disco, Inc. </I> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Michael Lafair, <I>CS Disco, Inc. </I> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Melissa Frug&eacute;, <I>CS Disco, Inc</I>. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Jodie Bourdet, <I>Cooley</I><I> LLP </I> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nicolas Dumont, <I>Cooley</I><I> LLP </I> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Trey Reilly, <I>Cooley</I><I> LLP</I> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Joanne Soslow, <I>Morgan, Lewis</I><I></I><I>&nbsp;&amp; Bockius LLP</I> </P></TD></TR></TABLE>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 500 Boylston Street, 14th Floor Boston, MA 02116-3736 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">t: (617) 937-2300 f: (617) 937-2400 cooley.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g176601g0610083319686.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g176601g0610083319686.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M (D# 2(  A$! Q$!_\0
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M/;1/$PP5*BO*O# ;P]\3)]+@<FW=VB(SU'4?E717GQ5TA+,M:13RW!'RHRX
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56'PE3E?[R>GHNOWFQ249HK4\L__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g176601g0630214312461.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g176601g0630214312461.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M (D# 2(  A$! Q$!_\0
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M/;1/$PP5*BO*O# ;P]\3)]+@<FW=VB(SU'4?E717GQ5TA+,M:13RW!'RHRX
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56'PE3E?[R>GHNOWFQ249HK4\L__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
